SCOPUS 정보 검색 플랫폼

Volumn 29, Issue 11, 2003, Pages 2094-2095

Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration

(7) Yagasaki, Kazuaki a Gando, Satoshi b Matsuda, Naoyuki b Kameue, Takashi b Ishitani, Toshiteru b Hirano, Takeshi a Iseki, Ken a

a HOKKAIDO UNIVERSITY (Japan)

b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TEICOPLANIN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CASE REPORT; CIRCULATION; CRITICAL ILLNESS; DOSE RESPONSE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEALTH STATUS; HEMODIALYSIS; HUMAN; MALE; ULTRAFILTRATION;

ADULT; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HALF-LIFE; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; LINEAR MODELS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MOLECULAR WEIGHT; TEICOPLANIN; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0345257048 PISSN: 03424642 EISSN: None Source Type: Journal
DOI: 10.1007/s00134-003-1914-9 Document Type: Article

Times cited : (26)

References (5)

1
- 0033800132
- Clinical pharmacokinetics of teicoplanin
- Wilson APR (2000) Clinical pharmacokinetics of teicoplanin. Drug Dispos 39:167-183
- (2000) Drug Dispos , vol.39 , pp. 167-183
- Wilson, A.P.R.¹

2
- 0242677656
- Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continous hemodiafiltration
- DOI 10.1007/s00134-003-1980-z
- Yagasaki K, Gando S, Matsuda M, Kameue T, Ishitani T, Hirano T, Iseki K (2003) Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continous hemodiafiltration. Intensive Care Med DOI 10.1007/s00134-003-1980-z
- (2003) Intensive Care Med
- Yagasaki, K.¹ Gando, S.² Matsuda, M.³ Kameue, T.⁴ Ishitani, T.⁵ Hirano, T.⁶ Iseki, K.⁷

3
- 0027218305
- Evaluation of a novel fluorescence polarization immunoassay for teicoplanin
- Cox H, Whitby M, Nimmo G, Williams G (1993) Evaluation of a novel fluorescence polarization immunoassay for teicoplanin. Antimicrob Agents Chemother 37:1924-1926
- (1993) Antimicrob Agents Chemother , vol.37 , pp. 1924-1926
- Cox, H.¹ Whitby, M.² Nimmo, G.³ Williams, G.⁴

4
- 8544276599
- Single-dose pharmacokinetics of teicoplanin during hemodiaslysis therapy using high-flux polysulfone membranes
- Thalhammer F, Rosenkranz AR, Burgmann H, Graninger W, Hollenstein U, Schenk P, Thalhammer-Scherrer R, Traindl O, Horl WH, Breyer S (1997) Single-dose pharmacokinetics of teicoplanin during hemodiaslysis therapy using high-flux polysulfone membranes. Wien Klin Wochenschr 109:362-365
- (1997) Wien Klin Wochenschr , vol.109 , pp. 362-365
- Thalhammer, F.¹ Rosenkranz, A.R.² Burgmann, H.³ Graninger, W.⁴ Hollenstein, U.⁵ Schenk, P.⁶ Thalhammer-Scherrer, R.⁷ Traindl, O.⁸ Horl, W.H.⁹ Breyer, S.¹⁰

5
- 0028605825
- Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis
- Wolter K, Claus M, Wagner K, Fritschka E (1994) Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis. Clin Nephrol 42:389-397
- (1994) Clin Nephrol , vol.42 , pp. 389-397
- Wolter, K.¹ Claus, M.² Wagner, K.³ Fritschka, E.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.